Medical device company IDEXX Laboratories, Inc. (NASDAQ: IDXX) on Monday reported higher revenues and earnings for the third quarter of fiscal 2025.
- Third-quarter revenue grew 13% year-over-year to $1.11 billion; sales rose 12% on an organic basis
- CAG Diagnostics recurring revenue increased 11% on a reported basis and 10% on an organic basis
- Livestock, Poultry, and Dairy revenue growth was 17% on a reported basis, and 14% organically
- Third-quarter earnings per share were $3.40, up 21% from last year; on a comparable basis, EPS growth is 15%
- The management raised its full-year revenue guidance range to $4.27-4.30 billion, or reported growth of 9.6-10.3%
- It also raised organic revenue growth guidance for FY25 to 8.8-9.5%, reflecting the operational performance benefits
- Reported operating margin outlook for the year has been raised to 31.6-31.8%
- The company updated its EPS outlook range to $12.81-13.01, incorporating a $0.33 increase at mid-point versus prior guidance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Citigroup set to report Q4 2025 earnings. Here’s what to expect
Citigroup Inc. (NYSE: C) has undergone a sweeping transformation in recent years, emerging as a more streamlined and profitable financial institution. The bank's performance in recent quarters has underscored the
Home Depot (HD), Lowe’s (LOW): Home improvement pressures not expected to abate soon
Home improvement retailers Home Depot (NYSE: HD) and Lowe’s Companies, Inc. (NYSE: LOW) have been facing a challenging operating environment for a while now. The companies have been battling macroeconomic
Earnings Summary: AngioDynamics (ANGO) Q2 FY26 sales increase 8.8%
Medical technology company AngioDynamics, Inc. (NASDAQ: ANGO) on Tuesday reported an increase in net sales for the second quarter of fiscal 2026. In Q2, net sales increased 8.8% year-over-year to
